Tayyebeh M. Nazeran

899 W 12th Ave
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Investigating the effect of human amniotic membrane gel to minimize adhesions in endometriosis: findings from an experimental study using a rat model.

Investigating the effect of human amniotic membrane gel to minimize adhesions in endometriosis: findings from an experimental study using a rat model.

Journal: Clinical and experimental reproductive medicine

Published: December 25, 2025

KRAS mutations and endometriosis burden of disease.

KRAS mutations and endometriosis burden of disease.

Journal: The journal of pathology. Clinical research

Published: December 27, 2022

Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.

Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.

Journal: Fertility and sterility

Published: November 16, 2021

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

Journal: The Journal of pathology

Published: September 04, 2021

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 06, 2020

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 11, 2020

Prognostic gene expression signature for high-grade serous ovarian cancer.

Prognostic gene expression signature for high-grade serous ovarian cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 04, 2020

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.

Journal: British journal of cancer

Published: January 01, 2020

Molecular profiling and molecular classification of endometrioid ovarian carcinomas.

Molecular profiling and molecular classification of endometrioid ovarian carcinomas.

Journal: Gynecologic oncology

Published: April 19, 2019

Oncogenic mutations in histologically normal endometrium: the new normal?

Oncogenic mutations in histologically normal endometrium: the new normal?

Journal: The Journal of pathology

Published: February 20, 2019

Histotype classification of ovarian carcinoma: A comparison of approaches.

Histotype classification of ovarian carcinoma: A comparison of approaches.

Journal: Gynecologic oncology

Published: June 21, 2018

Iatrogenic endometriosis harbors somatic cancer-driver mutations.

Iatrogenic endometriosis harbors somatic cancer-driver mutations.

Journal: Human reproduction (Oxford, England)

Published: April 25, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026